D. Gjermeni

Thrombelastography Compared with Multiple Impedance Aggregometry to Assess High On-Clopidogrel Reactivity in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

D. Trenk, D. Duerschmied, S. Leggewie, 2022, Journal of clinical medicine.

Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial

N. Kucher, G. Colucci, M. Schindewolf, 2022, The Lancet Haematology.

Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation

C. Olivier, V. Kühlkamp, D. Gjermeni, 2023, European heart journal open.

Low on-clopidogrel ADP- and TRAP-6-induced platelet aggregation in patients with atrial fibrillation undergoing percutaneous coronary intervention: an observational pilot study

S. Leggewie, P. Siegel, D. Gjermeni, 2024, Journal of thrombosis and thrombolysis.